Evidence map›Paper›PMID 39397107›Full record

ArticleCommunications biology2024

ARL13B controls male reproductive tract physiology through primary and Motile Cilia.

Céline Augière, Gabriel Campolina-Silva, Aaran Vijayakumaran, Odara Medagedara, Camille Lavoie-Ouellet, Charles Joly Beauparlant, Arnaud Droit, Ferran Barrachina, Kiera Ottino, Maria Agustina Battistone and 4 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. ARL13B-Cerulean rescuesbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Céline AugièreCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada. Celine.Augiere@crchudequebec.ulaval.ca.ORCID 0000-0002-5527-635X
Gabriel Campolina-SilvaCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada.ORCID 0000-0002-4473-3340
Aaran VijayakumaranMedical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, UK.
Odara MedagedaraMedical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, UK.
Camille Lavoie-OuelletCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada.
Charles Joly BeauparlantCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada.
Arnaud DroitCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada.ORCID 0000-0001-7922-790X
Ferran BarrachinaProgram in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, MA, USA.
Kiera OttinoProgram in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, MA, USA.
Maria Agustina BattistoneProgram in Membrane Biology, Nephrology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, MA, USA.ORCID 0000-0003-0490-9548
Kedar NarayanCenter for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Rex Hess *Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, IL, USA.ORCID 0000-0003-2649-3563
Vito Mennella *Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, UK.
Clémence BelleannéeCHU de Québec Research Center (CHUL)- Université Laval, Quebec City, QC, Canada. Clemence.Belleannee@crchudequebec.ulaval.ca.ORCID 0000-0001-9284-9420

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative SupplementR01HD104672 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI Maria Agustina Battistone · 2021 to 2026
$2.5M
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (Skin Research Training Centre) IC119871NCI NIH HHS 75N91019D00024NICHD NIH HHS R01 HD104672U.S. Department of Health & Human Services | National Institutes of Health (NIH) HD104672-01
6 · The paper itself

Abstract

ARL13B is a small regulatory GTPase that controls ciliary membrane composition in both motile cilia and non-motile primary cilia. In this study, we investigated the role of ARL13B in the efferent ductules, tubules of the male reproductive tract essential to male fertility in which primary and motile cilia co-exist. We used a genetically engineered mouse model to delete Arl13b in efferent ductule epithelial cells, resulting in compromised primary and motile cilia architecture and functions. This deletion led to disturbances in reabsorptive/secretory processes and triggered an inflammatory response. The observed male reproductive phenotype showed significant variability linked to partial infertility, highlighting the importance of ARL13B in maintaining a proper physiological balance in these small ducts. These results emphasize the dual role of both motile and primary cilia functions in regulating efferent duct homeostasis, offering deeper insights into how cilia related diseases affect the male reproductive system.

Indexed as

ADP-Ribosylation FactorsCiliaAnimalsEpididymisInfertility, MaleMaleMiceMice, Inbred C57BLMice, KnockoutADP-Ribosylation FactorsArl13b protein, mouse

Identifiers

PMID39397107
PMCPMC11471856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.